Allianz (ALIZY)
(Delayed Data from OTC)
$29.93 USD
-0.13 (-0.43%)
Updated Mar 28, 2024 03:59 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ALIZY 29.93 -0.13(-0.43%)
Will ALIZY be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for ALIZY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALIZY
Are Investors Undervaluing Allianz (ALIZY) Right Now?
Is Allianz (ALIZY) Stock Undervalued Right Now?
ALIZY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Ageas (AGESY) Stock?
Should Value Investors Buy Allianz (ALIZY) Stock?
Is Acadia Realty Trust (AKR) Stock Outpacing Its Finance Peers This Year?
Other News for ALIZY
Allianz Life Launches New Accumulation Annuity
AllianzIM Announces Net Asset Value Restatement for AllianzIM U.S. Large Cap Buffer10 Aug ETF (AUGT)
Allianz Technology shy of benchmark as 'magnificent seven' shine
DAX: Tepid Growth Forecasts Not Hindering Momentum
GLOBAL BROKER RATINGS: Ferrari cut to 'sell'; BP raised to 'buy'